What to do with an abnormal PSA test.
For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its adjunctive measurements.
Loeb
Stacy
S
Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Catalona
William J
WJ
D000465:Algorithms; D003657:Decision Making; D006801:Humans; D008297:Male; D008403:Mass Screening; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology; D012307:Risk Factors
D017430:Prostate-Specific Antigen